METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug boost chemo for tough cancers?
Disease control Not yet recruitingThis early-phase trial will test whether adding semaglutide (a GLP-1 drug used for diabetes and weight loss) to standard chemotherapy is safe and tolerable for people with metastatic pancreatic, colorectal, or liver cancer. About 30 participants will receive weekly semaglutide in…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New personalized vaccine takes on tough cancers
Disease control Not yet recruitingThis early-stage trial tests a personalized cancer vaccine called ODI-2001 in 77 people with advanced colon or pancreatic cancer that has spread or cannot be removed. The vaccine is custom-made for each patient's tumor and is given along with a drug that boosts the immune system.…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Triple threat: radiation and immunotherapy join chemo against pancreatic cancer
Disease control Not yet recruitingThis Phase III trial tests whether adding targeted radiation and an immunotherapy drug (serplulimab) to standard chemotherapy can help people with advanced pancreatic cancer live longer. About 198 participants who have not had prior treatment will be randomly assigned to receive …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental vaccine takes on tough pancreatic cancer
Disease control Not yet recruitingThis early-phase trial will test a new tumor vaccine (SapDM275) combined with standard chemotherapy in 13 people with metastatic pancreatic cancer who have not had prior treatment. The vaccine aims to help the immune system attack cancer cells. The main goal is to check safety, b…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC